S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PYPL   66.60 (+0.05%)
S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PYPL   66.60 (+0.05%)
S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PYPL   66.60 (+0.05%)
S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PYPL   66.60 (+0.05%)
OTCMKTS:VYNT

Vyant Bio (VYNT) Stock Price, News & Analysis

$0.19
+0.01 (+7.78%)
(As of 12/29/2023)
Today's Range
$0.18
$0.20
50-Day Range
$0.19
$0.19
52-Week Range
$0.14
$1.58
Volume
19,100 shs
Average Volume
161,822 shs
Market Capitalization
$1.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VYNT stock logo

About Vyant Bio Stock (OTCMKTS:VYNT)

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.

VYNT Stock Price History

VYNT Stock News Headlines

Vyant Bio Inc VYNT
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Vyant Bio Provides Update on Winddown Activities
CBOE shift unlocks new weekend income strategy
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. You're probably wondering, “Okay… But how does that affect me?” This perk now allows everyday traders like yourself to target extra income over the weekend.
Vyant Bio Announces Completion of StemoniX Asset Sale
AI Can Find Cancer’s Origin: Study
See More Headlines
Receive VYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vyant Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
3/28/2024
Next Earnings (Estimated)
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
OTCMKTS:VYNT
Employees
4
Year Founded
N/A

Profitability

Net Income
$-22,690,000.00
Net Margins
-3,474.81%
Pretax Margin
-3,281.86%

Debt

Sales & Book Value

Annual Sales
$670,000.00
Book Value
$1.69 per share

Miscellaneous

Free Float
5,724,000
Market Cap
$1.23 million
Optionable
Not Optionable
Beta
1.73
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

VYNT Stock Analysis - Frequently Asked Questions

How have VYNT shares performed in 2024?

Vyant Bio's stock was trading at $0.1940 at the beginning of the year. Since then, VYNT shares have increased by 0.0% and is now trading at $0.1940.
View the best growth stocks for 2024 here
.

When is Vyant Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our VYNT earnings forecast
.

How were Vyant Bio's earnings last quarter?

Vyant Bio, Inc. (OTCMKTS:VYNT) issued its earnings results on Thursday, November, 11th. The company reported ($0.75) earnings per share for the quarter, hitting the consensus estimate of ($0.75). The company had revenue of $1.51 million for the quarter, compared to the consensus estimate of $2.19 million. Vyant Bio had a negative net margin of 3,474.81% and a negative trailing twelve-month return on equity of 151.82%. During the same quarter in the prior year, the firm posted ($2.90) EPS.

When did Vyant Bio's stock split?

Vyant Bio shares reverse split on Wednesday, November 2nd 2022. The 1-5 reverse split was announced on Wednesday, November 2nd 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 2nd 2022. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

How do I buy shares of Vyant Bio?

Shares of VYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:VYNT) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners